VivoSim Labs, Inc. ( VIVS) - Key Metrics
VIVS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.02 | -$1.84 | -$1.55 | -$1.55 |
| 2026Q2 | $0.02 | -$1.74 | -$1.62 | -$1.62 |
| 2026Q1 | $0.03 | -$1.94 | -$2.69 | -$2.69 |
| 2025Q4 | $0.03 | $4.68 | -$1.39 | -$1.39 |
| 2025Q3 | $0.02 | -$2.29 | -$1.20 | -$1.20 |
VIVS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | -0.25 |
| 2026Q2 | ? | -0.42 |
| 2026Q1 | ? | -0.19 |
| 2025Q4 | ? | 0.09 |
| 2025Q3 | ? | -0.19 |
VIVS
Price: $1.10
52 week price:
Earnings Per Share: 1.76 USD
P/E Ratio: 0.63
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.2 million